Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-21-011395
Filing Date
2021-11-22
Accepted
2021-11-22 19:13:22
Documents
1
Period of Report
2021-11-18

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 12357
  Complete submission text file 0001062993-21-011395.txt   13832
Mailing Address 2735 SAND HILL ROAD MENLO PARK CA 94025
Business Address
ROOT JONATHAN D (Reporting) CIK: 0001225480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39866 | Film No.: 211434192

Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Issuer) CIK: 0001828522 (see all company filings)

EIN.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations